By Lina carolina 
The increasing legalization of marijuana across numerous states has fostered a public perception of relative safety. However, when examining the complex relationship between cannabis consumption and cancer, the scientific picture remains decidedly less clear. While tobacco smoking’s role as a primary driver of lung cancer has been definitively established over decades of rigorous research, experts are still actively working to unravel the precise mechanisms by which marijuana affects cancer risk. Dr. Brooks Udelsman, a thoracic surgeon affiliated with USC Surgery at Keck Medicine of USC, emphasizes that the ongoing scientific inquiry highlights the need for nuanced understanding, moving beyond broad assumptions of safety.
Unpacking the Emerging Evidence
Researchers are diligently investigating whether the act of smoking marijuana elevates the likelihood of developing various forms of cancer. A significant recent study conducted by Keck Medicine, spearheaded by Dr. Niels Kokot, an otolaryngologist at the USC Caruso Department of Otolaryngology—Head and Neck Surgery, has provided compelling evidence. This research indicated that individuals who reported consuming substantial quantities of marijuana appeared to face an increased risk of both small cell lung cancer and non-small cell lung cancer.
Further illuminating this connection, Dr. Kokot and his team published findings in another study detailing a stark correlation between daily marijuana use and the incidence of head and neck cancers. Their report indicated that individuals who used marijuana on a daily basis were between 3.5 to 5 times more likely to develop these cancers compared to non-users. These critically located cancers encompass those affecting the mouth, pharynx, larynx, oropharynx (which includes the tongue, tonsils, and the posterior wall of the throat), and adjacent salivary glands.
Defining "Too Much": The Elusive Dose-Response Relationship
Despite the accumulating evidence linking heavy marijuana smoking to an elevated cancer risk, a critical question remains unanswered: at what precise level of consumption does this risk begin to significantly escalate? Dr. Udelsman articulates this uncertainty, stating, "What we don’t know right now is the dose relationship." He elaborates on the spectrum of use, questioning whether occasional consumption, such as once a week, once a month, or only a few times a year, carries the same heightened risk. His professional intuition suggests that for such infrequent use, the risk is likely minimal. "All we know right now is that people who smoke a lot of marijuana—to the point that they develop a dependency on it or require hospital care or evaluation for it—do appear to have a higher cancer risk," he explains.
The scientific community’s scope of investigation extends beyond lung and head and neck cancers. Scientists are actively exploring potential links between heavy marijuana use and other malignancies, including bladder cancer and various gastrointestinal cancers. Drawing a parallel to tobacco, Dr. Udelsman notes, "With tobacco, we do see an increased prevalence of bladder cancer. Whether that relationship is also the same for heavy marijuana smoking, we don’t know." He underscores the imperative nature of this research: "That’s why we’re trying to determine what the risks are so that people can know what risks they’re taking."
Edibles vs. Inhalation: A Divergence in Risk?
The methods of marijuana consumption are as varied as the legal frameworks surrounding its use. While smoking remains a prominent method, current scientific evidence suggests that non-smoking alternatives, such as edibles, are unlikely to contribute to lung cancer risk. "Probably not," Dr. Udelsman states regarding the link between edibles and lung cancer. He acknowledges the limitations in available data, noting, "The risk is harder to track because there isn’t a lot of data on it yet, but as of now there does not seem to be a relationship between edibles and lung cancer." However, he cautions that the connection between edibles and other types of cancers remains an open question requiring further investigation.
The Biological Mechanisms: Inflammation and DNA Damage
The potential for marijuana smoke to increase cancer risk is rooted in biological processes similar to those observed with tobacco smoke. Dr. Udelsman explains that any substance causing prolonged inflammation in the body can, over time, elevate cancer risk. Tobacco smoke is a complex mixture containing over 7,000 chemicals, with approximately 70 definitively linked to cancer. Critically, some of these same carcinogenic chemicals are also present in marijuana smoke.
Furthermore, Dr. Udelsman highlights the role of THC (tetrahydrocannabinol), the primary psychoactive compound in marijuana. THC has been associated with the conversion of polycyclic aromatic hydrocarbons (PAHs) into more harmful compounds. PAHs are known environmental carcinogens that can induce chronic inflammation and directly damage DNA. "Anytime inflammation and changes to DNA occur, you’re at risk for developing cancer," he asserts, underscoring the fundamental cellular processes involved in carcinogenesis.
Secondhand Smoke: An Unresolved Concern
The impact of secondhand marijuana smoke on cancer risk is another area where definitive conclusions are still being formulated. While there is insufficient evidence to confirm a direct link to lung cancer, Dr. Udelsman posits that potential risks cannot be entirely dismissed. He suggests that individuals exposed to secondhand marijuana smoke may inhale inflammatory particles, which are believed to play a role in cancer development. The scientific community continues to monitor and study these effects to provide more concrete guidance.
Specific Lung Cancers and Their Association with Marijuana
Lung cancer is broadly categorized into two primary types: small cell lung cancer and non-small cell lung cancer. Small cell lung cancer exhibits a particularly strong and well-documented association with tobacco smoking. However, Dr. Udelsman indicates that this aggressive form of lung cancer may also be linked to marijuana smoking. He elaborates, "It’s almost unheard of to get small cell lung cancer without some type of inhalational injury," implying that inhaled irritants, including those found in marijuana smoke, could contribute to its development.
Non-small cell lung cancer, the more common of the two types, also appears with greater frequency among marijuana smokers. "We also see an increase in non-small cell lung cancer in smokers of both tobacco and marijuana, so both types are increased when compared to nonsmokers," Dr. Udelsman observes, reinforcing the notion that inhaled substances, regardless of their source, can have detrimental effects on lung health.
Vaping: A New Frontier of Uncertainty
The advent of electronic cigarettes and vaping devices introduced a new paradigm in substance consumption, initially lauded by some for their perceived reduced harm compared to traditional smoking. However, medical professionals are now observing a concerning rise in serious inflammatory lung diseases directly linked to vaping, though not yet definitively to cancer itself. "But we are starting to see some very severe inflammatory diseases—not cancers, but benign diseases—from vaping," Dr. Udelsman reports.
Given that vaping has only been prevalent for approximately 15 years, researchers have not yet accumulated sufficient longitudinal data to ascertain its long-term impact on lung cancer risk. This same uncertainty extends to the vaping of marijuana. "The data on vaping is very new, so we don’t know yet, but I’d worry about anything you’re breathing into your lungs because it infiltrates the cells and air sacs in your lungs, which can cause damage and put you at a higher risk for cancer," Dr. Udelsman cautions. The potential for chronic inflammation and cellular damage from inhaled aerosols remains a significant area of concern for public health.
The Crucial Distinction: Occasional vs. Chronic, Heavy Use
Despite the emerging concerns and the evidence linking heavy marijuana use to increased cancer risk, Dr. Udelsman expresses a degree of measured optimism regarding the broader public health implications for occasional recreational users. He does not foresee a widespread lung cancer epidemic driven by infrequent marijuana consumption. "I worry less about occasional use and the slight inflammation that it might cause for a temporary period. Your body probably recovers from that very quickly, with very little damage," he states.
His primary concern lies with chronic and heavy exposure. "I’m more worried about chronic, heavy exposure: people who are using marijuana every day, multiple times a day. That’s where I think you can start to build up injury. Those are the people data today shows are at risk for developing cancer, similar to tobacco," Dr. Udelsman emphasizes. This distinction is critical for public health messaging and individual risk assessment.
For individuals who identify as heavy marijuana users, consultation with a healthcare provider is strongly recommended. A medical professional can conduct a thorough evaluation of personal cancer risk, taking into account the individual’s specific consumption patterns, medical history, and other relevant lifestyle factors. This dialogue can also inform decisions about whether additional cancer screening or follow-up care may be appropriate, ensuring that individuals are empowered with knowledge and proactive management of their health. The ongoing research aims to provide a clearer, evidence-based understanding of these risks, enabling informed choices in an evolving legal and social landscape.
